Chemomab Therapeutics Ltd. Increase (Decrease) in Accrued Liabilities
Chemomab Therapeutics Ltd. (CMMB) reported Increase (Decrease) in Accrued Liabilities of -$1.20 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-03-23
- Chemomab Therapeutics Ltd. increase (decrease) in accrued liabilities for the quarter ending 2023-06-30 was -$661.00K, a 242.46% decline year-over-year.
- Chemomab Therapeutics Ltd. increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was -$214.00K, a 130.88% decline year-over-year.
- Chemomab Therapeutics Ltd. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was $801.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was $865.00K.
- Chemomab Therapeutics Ltd. increase (decrease) in accrued liabilities for fiscal 2020 was $392.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$1.20M 20-F · filed 2026-03-23 | ||||
| 2025-06-30 | -$915.00K 6-K · filed 2025-08-14 | ||||
| 2024-12-31 | -$1.89M 20-F · filed 2026-03-23 | -$1.86M 20-F · filed 2025-04-04 | |||
| 2024-06-30 | -$877.00K 6-K · filed 2025-08-14 | ||||
| 2023-12-31 | $45.00K 20-F · filed 2026-03-23 | ||||
| 2023-06-30 | -$661.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-08-21 | -$875.00K 6-K · filed 2024-08-21 | -$74.00K derived: sum of 3 quarters · filed 2025-04-04 | $791.00K derived: sum of 4 quarters · filed 2025-04-04 | |
| 2023-03-31 | -$214.00K 10-Q · filed 2023-05-11 | $587.00K derived: sum of 2 quarters · filed 2025-04-04 | $1.45M derived: sum of 3 quarters · filed 2025-04-04 | $1.92M derived: sum of 4 quarters · filed 2025-04-04 | |
| 2022-12-31 | $801.00K derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | $1.67M derived: sum of 2 quarters · filed 2025-04-04 | $2.13M derived: sum of 3 quarters · filed 2025-04-04 | $2.82M 20-F · filed 2025-04-04 | |
| 2022-09-30 | $865.00K derived: 10-Q 9 month − 6-K 6 month · filed 2022-11-10 | $1.33M derived: sum of 2 quarters · filed 2023-08-14 | $2.02M 10-Q · filed 2022-11-10 | $2.00M derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-06-30 | $464.00K derived: 6-K 6 month − 10-Q 3 month · filed 2023-08-14 | $1.16M 6-K · filed 2023-08-14 | $1.14M derived: sum of 3 quarters · filed 2024-03-28 | $871.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-03-31 | $693.00K 10-Q · filed 2023-05-11 | $675.00K derived: sum of 2 quarters · filed 2024-03-28 | $407.00K derived: sum of 3 quarters · filed 2024-03-28 | -$524.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2021-12-31 | -$18.00K derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | -$286.00K derived: sum of 2 quarters · filed 2024-03-28 | -$1.22M derived: sum of 3 quarters · filed 2024-03-28 | -$1.28M 20-F · filed 2024-03-28 | |
| 2021-09-30 | -$268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.20M derived: sum of 2 quarters · filed 2022-11-10 | -$1.26M 10-Q · filed 2022-11-10 | -$1.00M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$931.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$993.00K 10-Q · filed 2022-08-12 | -$732.00K derived: sum of 3 quarters · filed 2022-08-12 | -$334.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$62.00K 10-Q · filed 2022-05-12 | $199.00K derived: sum of 2 quarters · filed 2022-05-12 | $597.00K derived: sum of 3 quarters · filed 2022-05-12 | $534.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $659.00K derived: sum of 2 quarters · filed 2022-03-30 | $596.00K derived: sum of 3 quarters · filed 2022-03-30 | $392.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $335.00K derived: sum of 2 quarters · filed 2021-11-12 | $131.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$267.00K 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | -$204.00K 10-Q · filed 2021-05-13 |